You have 9 free searches left this month | for more free features.

apalutamide

Showing 1 - 25 of 62

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Apalutamide
  • +2 more
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)

Not yet recruiting
  • Prostate Cancer With ≤10 Bone Metastases
  • Apalutamide
  • +2 more
  • (no location specified)
Feb 22, 2023

Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Sep 6, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Apalutamide
  • Beijing, China
  • +3 more
Jan 17, 2023

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jan 13, 2023

Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Castration-Sensitive Prostate Cancer
  • apalutamide
  • +3 more
  • Shanghai, Shanghai, China
  • +1 more
Feb 4, 2023

Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))

Not yet recruiting
  • Metastatic Castrate-sensitive Prostate Cancer
  • Apalutamide
  • Androgen-deprivation Therapy (ADT)
  • Lakewood, Colorado
  • +5 more
May 23, 2023

Prostatic Tumors Trial in Worldwide (EPI-7386, Abiraterone Acetate, Prednisone or Prednisolone)

Suspended
  • Prostatic Neoplasms
  • Towson, Maryland
  • +3 more
Nov 3, 2022

Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • Omaha, Nebraska
  • +4 more
Nov 10, 2022

Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)

Not yet recruiting
  • Metastatic Cancer
  • Neoplasm, Prostate
  • Abiraterone acetate
  • +2 more
  • Bronx, New York
    James J. Peters VA Medical Center
Jun 16, 2022

Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

Completed
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022

Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)

Active, not recruiting
  • Castration-Resistant Prostate Cancer
  • Apalutamide
  • Greenville, South Carolina
  • +4 more
Aug 2, 2022

Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

Recruiting
  • Small Cell Neuroendocrine Carcinoma
  • +2 more
  • Apalutamide
  • Cetrelimab
  • San Francisco, California
    University of California, San Francisco
Mar 21, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment)

Terminated
  • Prostate Adenocarcinoma
  • Apalutamide
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 28, 2021

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Apalutamide
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +5 more
Jul 14, 2022

Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Apalutamide
  • Quality-of-Life Assessment
  • Tucson, Arizona
  • +4 more
Jun 28, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

Suspended
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Prostatic Tumors Trial in Brazil, Colombia, Mexico (Apalutamide, ADT (Standard of Care))

Available
  • Prostatic Neoplasms
  • Apalutamide
  • ADT (Standard of Care)
  • Florianopolis, Brazil
  • +19 more
Aug 2, 2022

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

High-Risk and Oligometastatic Prostate Cancer Trial (Apalutamide)

Not yet recruiting
  • High-Risk and Oligometastatic Prostate Cancer
  • Apalutamide
  • (no location specified)
Aug 2, 2021

Prostate Cancer Metastatic Trial in Omaha, New York (Apalutamide, Abiraterone acetate, Docetaxel)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Apalutamide
  • +3 more
  • Omaha, Nebraska
  • +1 more
Aug 26, 2021

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022